ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
Status:
Active, not recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
The objective of this pivotal trial is to assess the efficacy, safety and tolerability of
CyclASol in comparison to the vehicle for the treatment of signs and symptoms of Dry Eye
Disease (DED).